Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009
- PMID: 20177726
- DOI: 10.1007/s10096-010-0882-6
Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009
Abstract
Stenotrophomonas maltophilia is an important nosocomial pathogen, especially among immunocompromised patients. The objective of this study was to clarify the clinical characteristics, prognosis, and prognostic factors of patients with S. maltophilia bacteremia in Japan. The microbiology records of all patients with S. maltophilia bacteremia between January 1996 and April 2009 at Toranomon Hospital, Tokyo, Japan, were retrospectively reviewed. A total of 53 cases of bacteremia were identified. Thirty patients had an underlying hematological disorder, and 23 were receiving hematopoietic transplantation. The overall mortality rate was 51%. On univariate analysis, neutropenia (p < 0.01), the presence of a central venous catheter, and mixed infection with enterococci (p < 0.05) were significantly related to the mortality. Among these variables, neutropenia (p < 0.01) and mixed infection with enterococci (p < 0.05) were independent factors associated with mortality. In contrast, all eight patients in whom S. maltophilia was the etiologic agent of catheter-related infection survived following catheter removal. S. maltophilia is an important pathogen among immunocompromised patients, especially in the neutropenic phase or mixed infection with enterococci. If a central venous catheter was present at the onset of S. maltophilia bacteremia, the prompt removal of the catheter was important.
Similar articles
-
Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.J Microbiol Immunol Infect. 2006 Apr;39(2):144-9. J Microbiol Immunol Infect. 2006. PMID: 16604247
-
Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.J Hosp Infect. 2012 Jun;81(2):114-8. doi: 10.1016/j.jhin.2012.02.008. Epub 2012 Apr 10. J Hosp Infect. 2012. PMID: 22494851
-
Seven-year evaluation of Stenotrophomonas maltophilia bacteremia in a university-affiliated hospital.J Infect Dev Ctries. 2025 Apr 29;19(4):498-503. doi: 10.3855/jidc.20243. J Infect Dev Ctries. 2025. PMID: 40305526
-
Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis.Infect Dis (Lond). 2024 May;56(5):335-347. doi: 10.1080/23744235.2024.2324365. Epub 2024 Mar 4. Infect Dis (Lond). 2024. PMID: 38436567 Review.
-
Stenotrophomonas maltophilia endocarditis.Scand J Infect Dis. 2002;34(12):925-7. doi: 10.1080/0036554021000026977. Scand J Infect Dis. 2002. PMID: 12587628 Review.
Cited by
-
Extracellular enzyme profiling of Stenotrophomonas maltophilia clinical isolates.Virulence. 2014 Feb 15;5(2):326-30. doi: 10.4161/viru.27724. Epub 2014 Jan 21. Virulence. 2014. PMID: 24448556 Free PMC article. No abstract available.
-
Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.Afr Health Sci. 2016 Mar;16(1):149-52. doi: 10.4314/ahs.v16i1.20. Afr Health Sci. 2016. PMID: 27358626 Free PMC article.
-
Clinical challenges treating Stenotrophomonas maltophilia infections: an update.JAC Antimicrob Resist. 2022 May 5;4(3):dlac040. doi: 10.1093/jacamr/dlac040. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35529051 Free PMC article. Review.
-
Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.BMC Infect Dis. 2019 Aug 28;19(1):754. doi: 10.1186/s12879-019-4394-4. BMC Infect Dis. 2019. PMID: 31462215 Free PMC article.
-
Stenotrophomonas maltophilia right-sided endocarditis in an adult patient with uncorrected congenital heart disease.IDCases. 2019 May 14;17:e00562. doi: 10.1016/j.idcr.2019.e00562. eCollection 2019. IDCases. 2019. PMID: 31193537 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous